US Patent 10196643 Immunostimulatory sequence oligonucleotides and methods of using the same

Is a

Patent

Patent attributes

Patent Applicant

Dynavax Technologies

Current Assignee

Dynavax Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

101966430

Patent Inventor Names

Dino Dina0

Jason Marshall0

Karen L. Fearon0

Date of Patent

February 5, 2019

Patent Application Number

152325020

Date Filed

August 9, 2016

Patent Citations Received

‌

US Patent 11957788 Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

‌

US Patent 10837018 Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

‌

US Patent 10894963 Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

‌

US Patent 11696954 Synthesis of spherical nucleic acids using lipophilic moieties

‌

US Patent 11312965 Immunostimulatory sequence oligonucleotides and methods of using the same

‌

US Patent 11364304 Crosslinked micellar spherical nucleic acids

Patent Primary Examiner

‌

Nita M. Minnifield

Patent abstract

The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10196643 Immunostimulatory sequence oligonucleotides and methods of using the same

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10196643 Immunostimulatory sequence oligonucleotides and methods of using the same